Association of chromosome 10 losses and negative prognosis in oligoastrocytomas
- 22 November 2002
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 52 (6) , 842-845
- https://doi.org/10.1002/ana.10405
Abstract
Oligoastrocytomas are mixed gliomas harboring different genetic alterations and with heterogeneous clinical evolution. We have looked for correlations between genetic losses and clinical evolution in 34 oligoastrocytomas. Loss of heterozygosity (LOH) with different microsatellite markers was studied on chromosomes 1p, 10q, 17p, and 19q. LOH on 1p was found in 44% of the tumors, on 10q in 24%, on 17p in 18%, and on 19q in 38%. LOH on 1p and 19q was combined in 29% of the patients. LOH on 1p was associated with significantly longer overall survival (p = 0.0092) and LOH on 10q with shorter overall survival (p = 0.0206). The observation that LOH on 10q predicts a short survival in oligoastrocytomas is novel and provides further evidence that genetic analysis may help to predict the clinical evolution of different gliomas, giving a more rationale basis to therapeutic options.Keywords
This publication has 11 references indexed in Scilit:
- Genetic Signature of Oligoastrocytomas Correlates with Tumor Location and Denotes Distinct Molecular SubsetsThe American Journal of Pathology, 2002
- PTEN Is a Target of Chromosome 10q Loss in Anaplastic Oligodendrogliomas and PTEN Alterations Are Associated with Poor PrognosisThe American Journal of Pathology, 2001
- Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed OligoastrocytomasJournal of Clinical Oncology, 2000
- Molecular pathogenesis of malignant gliomasCurrent Opinion in Oncology, 1999
- Complications and Expected Outcome of Glioma SurgeryJournal of Neuro-Oncology, 1999
- Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic OligodendrogliomasJNCI Journal of the National Cancer Institute, 1998
- Molecular Genetic Evidence for Subtypes of OligoastrocytomasJournal of Neuropathology and Experimental Neurology, 1997
- Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomasJournal of Neurosurgery, 1996
- Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Shared Allelic Losses on Chromosomes 1p and 19q Suggest a Common Origin of Oligodendroglioma and OligoastrocytomaJournal of Neuropathology and Experimental Neurology, 1995